Skip to content

13F-HR filed by REGENERON PHARMACEUTICALS, INC.

REGENERON PHARMACEUTICALS, INC. filed this 13F-HR for the quarter ended 2026-09-30, accepted by EDGAR 2026-11-05 21:05:55 UTC, with 3 holding rows worth $179,631,814.

Accession
0001104659-26-123321
Filed
2026-11-05
Accepted by EDGAR
Ingested
Source
EDGAR live feed

Original filing

13F report for Q3 2026

A holdings report, 3 entries on the cover page, a total value of $179,631,814 stated on the cover page (in dollars after the unit check, H1), rows summing to $179,631,814 with VALUE read as dollars as filed, 13F file number 028-24826. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
PARABILIS MEDICINES INC COM698955101Stock4,166,666$134,541,645dollars as filed
INTELLIA THERAPEUTICS INC45826J105COM3,702,995$44,658,120dollars as filed
ADICET BIO INC007002207COM NEW60,511$432,049dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001104659-26-123321this filing2026-11-05